There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

The original LuX-Valve system was associated with 10.3% mortality and 4.0% hospitalization for heart failure at 1 year when ...

The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.

Integrating multiple contradictory properties into a single material is crucial for dynamic soft tissue defect repair but difficult. Here, the authors report a super-structured porous hydrogel ...

Pitted against more established balloon-expandable Sapien 3 valves in TAVR for severe aortic stenosis, the Myval devices ...

The DapaTAVI trial assessed the benefits of dapagliflozin in patients discharged after TAVI with a history of heart failure plus 1 of the following comorbidities: LVEF ≤40%, diabetes, or renal ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available medical therapy plus a minimally invasive procedure using a clip to repair ...

Highly anticipated: It's finally happening. We've long heard about the general release of SteamOS, but Valve has now made it official with the launch of a new version of the operating system.

Valve’s Index headset was a market leader among PC VR headsets for years, but is it still worth buying in 2025 now that it’s nearly six years old? Read on for our no-nonsense recommendation.

The primary outcome was a composite of heart failure-related hospitalization ... including transcatheter interventions for mitral and tricuspid valves," says Dr. Kaneko. The research emphasizes ...